Lactobacillus

Generic Name: Lactobacillus

Indication: 主要用于消化不良以及场内异常发酵，小儿饮食不当引起的腹泻及营养不良等；也用于使用抗生素及放、化疗后引起的菌群失调性腹泻及急性肠胃炎、腹泻、痢疾等。

Clinical Trials

Decreasing Rates of Illness in Kids (DRINK)

Phase 3

Completed

Conditions: Healthy

First Posted Date: 2006-07-26

Last Posted Date: 2008-05-14

Lead Sponsor: Georgetown University

Target Recruit Count: 638

Registration Number: NCT00356382

Locations: 🇺🇸
Georgetown University Department of Family Medicine, Washington, District of Columbia, United States

Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection

Phase 2

Completed

Conditions: Urinary Tract Infection

Interventions: Drug: Placebo
Drug: Lactin-V

First Posted Date: 2006-03-21

Last Posted Date: 2023-04-14

Lead Sponsor: University of Washington

Target Recruit Count: 100

Registration Number: NCT00305227

Locations: 🇺🇸
Hall Health Primary Care Center, University of Washington, Seattle, Washington, United States

Addition of Lactobacillus to Metronidazole in Treatment of CDAD

Phase 4

Withdrawn

Conditions: Enterocolitis
Pseudomembranous Colitis
Antibiotic-associated Colitis

Interventions: Drug: Lactobacillus GG

First Posted Date: 2006-03-20

Last Posted Date: 2017-05-10

Lead Sponsor: Michael E. DeBakey VA Medical Center

Registration Number: NCT00304863

Locations: 🇺🇸
Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, United States

Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity

Phase 3

Terminated

Conditions: Bacterial Vaginosis
Premature Birth
Sepsis
Periventricular Leukomalacia
Bronchopulmonary Dysplasia

First Posted Date: 2006-03-15

Last Posted Date: 2011-06-15

Lead Sponsor: Oswaldo Cruz Foundation

Target Recruit Count: 645

Registration Number: NCT00303082

Locations: 🇧🇷
Hospital Maternidade Alexander Fleming, Rio de Janeiro, Brazil
🇧🇷
Hospital Maternidade Carmela Dutra, Rio de Janeiro, Brazil

The Effect of Prophylactic Probiotic Lactobacilli in Enteral Feeding on Nosocomial Pneumonia Rates in Critically Ill Patients

Not Applicable

Completed

Conditions: Critical Illness

Interventions: Other: Lactose Powder
Drug: Probiotic Lactobacillus

First Posted Date: 2005-11-21

Last Posted Date: 2015-11-20

Lead Sponsor: Melbourne Health

Target Recruit Count: 57

Registration Number: NCT00256087

Locations: 🇦🇺
Intensive Care Unit Royal Melbourne Hospital Grattan Street, Parkville, Victoria, Australia

The Effect of Prophylactic Pre Operative Probiotic Therapy on Endotoxin Levels in Cardiac Surgery Patients

Not Applicable

Withdrawn

Conditions: Preoperative Cardiac Surgery Patients

Interventions: Drug: Lactobacillus Probiotic
Other: Lactose Powder

First Posted Date: 2005-11-21

Last Posted Date: 2015-11-20

Lead Sponsor: Melbourne Health

Registration Number: NCT00256022

Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis

Not Applicable

Completed

Conditions: Atopic Dermatitis
Atopic Eczema
Infantile Eczema

First Posted Date: 2005-09-23

Last Posted Date: 2006-09-27

Lead Sponsor: Groningen Research Institute for Asthma and COPD

Target Recruit Count: 45

Registration Number: NCT00224432

Locations: 🇳🇱
Beatrix Children's Hospital, University Medical Center Groningen, Groningen, Netherlands

Lactobacillus GG Supplementation During Pediatric Burn Injuries

Not Applicable

Terminated

Conditions: Burns

First Posted Date: 2005-09-22

Last Posted Date: 2008-01-07

Lead Sponsor: Shriners Hospitals for Children

Target Recruit Count: 3

Registration Number: NCT00220519

Locations: 🇺🇸
Shriners Hospitals for Children, Boston, Massachusetts, United States

Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai Portoenterostomy

Not Applicable

Completed

Conditions: Biliary Atresia

Interventions: Drug: Lactobacillus casei rhamnosus (Lcr35)
Drug: Neomycin

First Posted Date: 2005-09-14

Last Posted Date: 2013-08-21

Lead Sponsor: National Taiwan University Hospital

Target Recruit Count: 30

Registration Number: NCT00166868

Locations: 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan

Lactobacillus Plantarum as Therapy for NK-T Cell Deficiency

Not Applicable

Completed

Conditions: Diabetes Mellitus

First Posted Date: 2001-02-14

Last Posted Date: 2005-06-24

Lead Sponsor: National Center for Research Resources (NCRR)

Registration Number: NCT00011141

Locations: 🇺🇸
Cornell University, New York, New York, United States

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy